Fate Therapeutics Inc (FATE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

3535 GENERAL ATOMICS COURT SAN DIEGO, CA 92121

Fate Therapeutics, Inc provides biotechnology services. The company researches and develops therapies to repair and regenerate body tissues with the help of stem cells.

Data based on most recent fiscal year report
Market Cap1.844 Billion Shares Outstanding75.59 Million Avg Volume1.049 Million
1-Yr BETA vs S&P TR1.367 Current Ratio7.53 Quick Ratio7.53
View SEC Filings from FATE instead.

View recent insider trading info

Funds Holding FATE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FATE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

29.6 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RASTETTER WILLIAM H

  • Director
28,461 2020-03-30 2

AGARWAL SHEFALI CHIEF MEDICAL OFFICER

  • Officer
71,991 2020-03-24 2

ENYEDY MARK J

  • Director
0 2020-03-17 0

WEYER CHRISTIAN EVP, RESEARCH & DEVELOPMENT

  • Officer
17,367 2020-02-27 0

JOOSS KARIN SEE REMARKS

  • Officer
0 2020-02-25 1

MULTANI PRATIK S

  • Director
0 2020-02-21 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
1,161,458 2020-02-10 3

LEE MICHAEL STEWART

  • Director
0 2020-02-05 1

VALAMEHR BAHRAM CHIEF DEVELOPMENT OFFICER

  • Officer
87,211 2020-02-03 3

WOLCHKO J SCOTT PRESIDENT AND CEO

  • Officer
  • Director
419,969 2020-01-30 7

SHOEMAKER DANIEL D CHIEF SCIENTIFIC OFFICER

  • Officer
143,091 2020-01-08 4

TAHL CINDY GENERAL COUNSEL AND SECRETARY

  • Officer
99,518 2020-01-08 2

NASHAT AMIR

  • Director
2,310,432 2019-07-31 5

EPSTEIN ROBERT S

  • Director
0 2019-06-12 1

COUGHLIN TIMOTHY P

  • Director
0 2019-05-08 1

MENDLEIN JOHN

  • Director
0 2019-05-08 1

ABBOT STEWART CHIEF DEVELOPMENT OFFICER

  • Officer
64,917 2018-05-15 0

STORGARD CHRIS CHIEF MEDICAL OFFICER

  • Officer
0 2018-01-16 0

FLYNN PETER D EVP, HEAD OF GLOBAL DEV

  • Officer
0 2017-10-13 0

FATE THERAPEUTICS INC CHIEF SCIENTIFIC OFFICER

  • Officer
103,816 2016-01-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RASTETTER WILLIAM H - Director

2020-03-30 M 28,461 $1.37 a 28,461 28,461.00 direct

RASTETTER WILLIAM H - Director

2020-03-30 M 28,461 d 0 28,461.00 direct

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2020-02-03 M 1,153 $1.69 a 87,211 87,211.00 direct

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2020-02-03 M 1,153 d 0 87,211.00 direct

Elevate your investments